ASCO 2026: Sustained MRD and Outcomes in Multiple Myeloma
/ Mattia D' Agostino
EHA 2026: Teclistamab Outcomes in High-Risk Extramedullary Myeloma
/ Astrid Hundebøll Torpe
EHA 2026: Circulating Tumor Plasma Cells Predict Progression in Smoldering Myeloma
/ Sigrun Thorsteinsdottir
ASH 2025: Interessante nye behandlinger af myelomatose på vej
/ Ida Bruun Kristensen
Flere patienter med myelomatose kan nu behandles med CAR-T
/ Charlotte Toftmann Hansen / Jan Andreasen
Higher-Than-Recommended Lenalidomide Dosing Is Safe in Transplant-Eligible Newly Diagnosed Multiple Myeloma with Renal Impairment
/ Frida Bugge Askeland / Jan Andreasen
BPd Preserved or Improved Quality of Life in Patients with RRMM
/ Paul G. Richardson / Jan Andreasen











